ECM
CODX

ExodusPoint Capital Management’s Co-Diagnostics CODX Stock Holding History

ExodusPoint Capital Management’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,667
Closed -$680K – 2016
2020
Q3 		$680K Buy
+1,667
New +$856K 0.01% 857

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ExodusPoint Capital Management's CODX Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Co-Diagnostics (CODX) in Q2 2022, closing a stake of 443 shares — an estimated $82K sold.

ExodusPoint Capital Management first reported a position in CODX in Q1 2020 and held it in 5 quarters. The position peaked at $534K in Q2 2021. 69 funds tracked by Wall St. Rank hold CODX as of Q2 2022.

  • ExodusPoint Capital Management reported no remaining Co-Diagnostics position as of Q2 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 443 Co-Diagnostics shares in Q2 2022, an estimated $82K.
  • ExodusPoint Capital Management first reported a position in Co-Diagnostics in Q1 2020 and held it in 5 quarters.
  • ExodusPoint Capital Management's Co-Diagnostics position peaked at $534K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.